vs

Side-by-side financial comparison of Dayforce (DAY) and Lantheus Holdings, Inc. (LNTH). Click either name above to swap in a different company.

Dayforce is the larger business by last-quarter revenue ($481.6M vs $406.8M, roughly 1.2× Lantheus Holdings, Inc.). Lantheus Holdings, Inc. runs the higher net margin — 13.3% vs -40.9%, a 54.2% gap on every dollar of revenue. On growth, Dayforce posted the faster year-over-year revenue change (9.5% vs 4.0%). Over the past eight quarters, Dayforce's revenue compounded faster (9.8% CAGR vs 4.9%).

Dayforce, Inc., formerly Ceridian, is an American human resources software and services company.

Lantheus Holdings, Inc. is a global healthcare firm specializing in the development, manufacturing and commercialization of innovative diagnostic imaging agents and related solutions. Its offerings cover core medical segments including oncology, cardiology and urology, with primary markets across North America and other key global regions.

DAY vs LNTH — Head-to-Head

Bigger by revenue
DAY
DAY
1.2× larger
DAY
$481.6M
$406.8M
LNTH
Growing faster (revenue YoY)
DAY
DAY
+5.4% gap
DAY
9.5%
4.0%
LNTH
Higher net margin
LNTH
LNTH
54.2% more per $
LNTH
13.3%
-40.9%
DAY
Faster 2-yr revenue CAGR
DAY
DAY
Annualised
DAY
9.8%
4.9%
LNTH

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
DAY
DAY
LNTH
LNTH
Revenue
$481.6M
$406.8M
Net Profit
$-196.8M
$54.1M
Gross Margin
59.2%
Operating Margin
6.3%
19.0%
Net Margin
-40.9%
13.3%
Revenue YoY
9.5%
4.0%
Net Profit YoY
-9940.0%
558.8%
EPS (diluted)
$-1.23
$0.86

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DAY
DAY
LNTH
LNTH
Q4 25
$406.8M
Q3 25
$481.6M
$384.0M
Q2 25
$464.7M
$378.0M
Q1 25
$481.8M
$372.8M
Q4 24
$465.2M
$391.1M
Q3 24
$440.0M
$378.7M
Q2 24
$423.3M
$394.1M
Q1 24
$431.5M
$370.0M
Net Profit
DAY
DAY
LNTH
LNTH
Q4 25
$54.1M
Q3 25
$-196.8M
$27.8M
Q2 25
$21.3M
$78.8M
Q1 25
$14.9M
$72.9M
Q4 24
$10.8M
$-11.8M
Q3 24
$2.0M
$131.1M
Q2 24
$-1.8M
$62.1M
Q1 24
$7.1M
$131.1M
Gross Margin
DAY
DAY
LNTH
LNTH
Q4 25
59.2%
Q3 25
57.9%
Q2 25
63.8%
Q1 25
63.8%
Q4 24
47.0%
63.5%
Q3 24
45.8%
63.9%
Q2 24
44.1%
64.9%
Q1 24
47.6%
65.4%
Operating Margin
DAY
DAY
LNTH
LNTH
Q4 25
19.0%
Q3 25
6.3%
11.4%
Q2 25
9.1%
23.3%
Q1 25
6.4%
27.4%
Q4 24
6.1%
29.1%
Q3 24
4.7%
35.3%
Q2 24
3.3%
26.1%
Q1 24
9.4%
28.8%
Net Margin
DAY
DAY
LNTH
LNTH
Q4 25
13.3%
Q3 25
-40.9%
7.2%
Q2 25
4.6%
20.8%
Q1 25
3.1%
19.6%
Q4 24
2.3%
-3.0%
Q3 24
0.5%
34.6%
Q2 24
-0.4%
15.8%
Q1 24
1.6%
35.4%
EPS (diluted)
DAY
DAY
LNTH
LNTH
Q4 25
$0.86
Q3 25
$-1.23
$0.41
Q2 25
$0.13
$1.12
Q1 25
$0.09
$1.02
Q4 24
$0.07
$-0.18
Q3 24
$0.01
$1.79
Q2 24
$-0.01
$0.88
Q1 24
$0.04
$1.87

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DAY
DAY
LNTH
LNTH
Cash + ST InvestmentsLiquidity on hand
$627.6M
$359.1M
Total DebtLower is stronger
$631.1M
$568.7M
Stockholders' EquityBook value
$2.7B
$1.1B
Total Assets
$8.7B
$2.2B
Debt / EquityLower = less leverage
0.23×
0.52×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DAY
DAY
LNTH
LNTH
Q4 25
$359.1M
Q3 25
$627.6M
$382.0M
Q2 25
$625.2M
$695.6M
Q1 25
$557.3M
$938.5M
Q4 24
$579.7M
$912.8M
Q3 24
$494.1M
$866.4M
Q2 24
$465.4M
$757.0M
Q1 24
$392.5M
$718.3M
Total Debt
DAY
DAY
LNTH
LNTH
Q4 25
$568.7M
Q3 25
$631.1M
$567.9M
Q2 25
$631.8M
$566.8M
Q1 25
$632.4M
$566.1M
Q4 24
$1.2B
$565.3M
Q3 24
$1.2B
$613.0K
Q2 24
$1.2B
$563.2M
Q1 24
$1.2B
$562.5M
Stockholders' Equity
DAY
DAY
LNTH
LNTH
Q4 25
$1.1B
Q3 25
$2.7B
$1.1B
Q2 25
$2.7B
$1.2B
Q1 25
$2.6B
$1.2B
Q4 24
$2.5B
$1.1B
Q3 24
$2.6B
$1.2B
Q2 24
$2.5B
$1.0B
Q1 24
$2.4B
$945.5M
Total Assets
DAY
DAY
LNTH
LNTH
Q4 25
$2.2B
Q3 25
$8.7B
$2.3B
Q2 25
$8.5B
$2.1B
Q1 25
$9.5B
$2.1B
Q4 24
$9.1B
$2.0B
Q3 24
$8.1B
$2.0B
Q2 24
$9.0B
$1.9B
Q1 24
$10.8B
$1.8B
Debt / Equity
DAY
DAY
LNTH
LNTH
Q4 25
0.52×
Q3 25
0.23×
0.51×
Q2 25
0.23×
0.49×
Q1 25
0.24×
0.49×
Q4 24
0.47×
0.52×
Q3 24
0.47×
0.00×
Q2 24
0.49×
0.55×
Q1 24
0.50×
0.59×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DAY
DAY
LNTH
LNTH
Operating Cash FlowLast quarter
$31.2M
$90.2M
Free Cash FlowOCF − Capex
$81.4M
FCF MarginFCF / Revenue
20.0%
Capex IntensityCapex / Revenue
2.2%
Cash ConversionOCF / Net Profit
1.67×
TTM Free Cash FlowTrailing 4 quarters
$354.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DAY
DAY
LNTH
LNTH
Q4 25
$90.2M
Q3 25
$31.2M
$105.3M
Q2 25
$112.7M
$87.1M
Q1 25
$49.6M
$107.6M
Q4 24
$81.0M
$157.7M
Q3 24
$91.8M
$175.1M
Q2 24
$99.2M
$84.7M
Q1 24
$9.1M
$127.2M
Free Cash Flow
DAY
DAY
LNTH
LNTH
Q4 25
$81.4M
Q3 25
$94.7M
Q2 25
$79.1M
Q1 25
$98.8M
Q4 24
$141.4M
Q3 24
$159.3M
Q2 24
$73.5M
Q1 24
$119.0M
FCF Margin
DAY
DAY
LNTH
LNTH
Q4 25
20.0%
Q3 25
24.7%
Q2 25
20.9%
Q1 25
26.5%
Q4 24
36.1%
Q3 24
42.0%
Q2 24
18.7%
Q1 24
32.2%
Capex Intensity
DAY
DAY
LNTH
LNTH
Q4 25
2.2%
Q3 25
2.8%
Q2 25
2.1%
Q1 25
2.3%
Q4 24
4.2%
Q3 24
4.2%
Q2 24
2.8%
Q1 24
2.2%
Cash Conversion
DAY
DAY
LNTH
LNTH
Q4 25
1.67×
Q3 25
3.79×
Q2 25
5.29×
1.11×
Q1 25
3.33×
1.47×
Q4 24
7.50×
Q3 24
45.90×
1.34×
Q2 24
1.36×
Q1 24
1.28×
0.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DAY
DAY

Dayforce Recurring$333.0M69%
Cloud And Bureau Professional Services And Other$78.5M16%
Float$42.2M9%
Powerpay Recurring$19.7M4%
Other Recurring$8.2M2%

LNTH
LNTH

Radiopharmaceutical Oncology$240.2M59%
Definity$85.3M21%
Strategic Partnerships And Other$23.3M6%
Techne Lite$21.0M5%
Licenseand Royalty Revenues$17.4M4%
Other$13.6M3%
Other Precision Diagnostics$5.9M1%

Related Comparisons